CARLA HAUSRATH: Open Payments
NPI 1508095399 · PLATTSBURGH, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$977 in 57 payments from 14 companies in 2025. Trend: 2023 $972 · 2024 $673 · 2025 $977
Food & beverage: $977
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $199 |
| PFIZER INC. | 22 | $199 |
| AstraZeneca Pharmaceuticals LP | 7 | $170 |
| Novo Nordisk Inc | 7 | $143 |
| Lilly USA, LLC | 2 | $46 |
| Lundbeck LLC | 1 | $32 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
| Dexcom, Inc. | 1 | $25 |
| Phathom Pharmaceuticals, Inc. | 1 | $24 |
Products named: NURTEC ODT, FARXIGA, UBRELVY, QULIPTA, Ozempic, Wegovy, MOUNJARO, REXULTI.
Industry payments across NY — which companies pay providers there.
